Akums Drugs and Pharmaceutical (NSE:AKUMS) — Market Cap & Net Worth
Market Cap & Net Worth: Akums Drugs and Pharmaceutical (AKUMS)
Akums Drugs and Pharmaceutical (NSE:AKUMS) has a market capitalization of $1.09 Billion (Rs100.79 Billion) as of August 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #8397 globally and #422 in its home market, demonstrating a -5.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Akums Drugs and Pharmaceutical's stock price Rs658.35 by its total outstanding shares 153102058 (153.10 Million). See Akums Drugs and Pharmaceutical (AKUMS) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Akums Drugs and Pharmaceutical Market Cap History: 2024 to 2026
Akums Drugs and Pharmaceutical's market capitalization history from 2024 to 2026. Data shows change from $1.06 Billion to $1.09 Billion (-9.14% CAGR).
Index Memberships
Akums Drugs and Pharmaceutical is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.17 Trillion | 0.03% | #336 of 500 |
|
NIFTY SMALLCAP 250
NISM250
|
$392.16 Billion | 0.28% | #151 of 250 |
Weight: Akums Drugs and Pharmaceutical's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Akums Drugs and Pharmaceutical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Akums Drugs and Pharmaceutical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Akums Drugs and Pharmaceutical's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.22x
Akums Drugs and Pharmaceutical's market cap is 0.22 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.06 Billion | $40.20 Billion | -$40.35 Million | 0.03x | N/A |
| 2025 | $750.71 Million | $40.71 Billion | $3.38 Billion | 0.02x | 0.22x |
Competitor Companies of AKUMS by Market Capitalization
Companies near Akums Drugs and Pharmaceutical in the global market cap rankings as of August 4, 2026.
Key companies related to Akums Drugs and Pharmaceutical by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Akums Drugs and Pharmaceutical Historical Marketcap From 2024 to 2026
Between 2024 and today, Akums Drugs and Pharmaceutical's market cap moved from $1.06 Billion to $ 1.09 Billion, with a yearly change of -9.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.09 Billion | +45.20% |
| 2025 | Rs750.71 Million | -28.98% |
| 2024 | Rs1.06 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Akums Drugs and Pharmaceutical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.09 Billion USD |
| MoneyControl | $1.09 Billion USD |
| MarketWatch | $1.09 Billion USD |
| marketcap.company | $1.09 Billion USD |
| Reuters | $1.09 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Akums Drugs and Pharmaceutical
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and co… Read more